Highlights

[HEXTAR] YoY Quarter Result on 2012-12-31 [#1]

Stock [HEXTAR]: HEXTAR GLOBAL BERHAD
Announcement Date 28-Feb-2013
Admission Sponsor -
Sponsor -
Financial Year 30-Sep-2013
Quarter 31-Dec-2012  [#1]
Profit Trend QoQ -     -24.85%    YoY -     -33.99%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 31,244 28,023 22,804 21,977 25,113 24,254 22,944 6.06%
  YoY % 11.49% 22.89% 3.76% -12.49% 3.54% 5.71% -
  Horiz. % 136.18% 122.14% 99.39% 95.79% 109.45% 105.71% 100.00%
PBT 1,179 897 750 934 1,585 1,461 1,399 -3.21%
  YoY % 31.44% 19.60% -19.70% -41.07% 8.49% 4.43% -
  Horiz. % 84.27% 64.12% 53.61% 66.76% 113.30% 104.43% 100.00%
Tax -407 -377 -302 -202 -476 -472 -362 2.26%
  YoY % -7.96% -24.83% -49.50% 57.56% -0.85% -30.39% -
  Horiz. % 112.43% 104.14% 83.43% 55.80% 131.49% 130.39% 100.00%
NP 772 520 448 732 1,109 989 1,037 -5.47%
  YoY % 48.46% 16.07% -38.80% -33.99% 12.13% -4.63% -
  Horiz. % 74.45% 50.14% 43.20% 70.59% 106.94% 95.37% 100.00%
NP to SH 772 520 448 732 1,109 989 1,037 -5.47%
  YoY % 48.46% 16.07% -38.80% -33.99% 12.13% -4.63% -
  Horiz. % 74.45% 50.14% 43.20% 70.59% 106.94% 95.37% 100.00%
Tax Rate 34.52 % 42.03 % 40.27 % 21.63 % 30.03 % 32.31 % 25.88 % 5.64%
  YoY % -17.87% 4.37% 86.18% -27.97% -7.06% 24.85% -
  Horiz. % 133.38% 162.40% 155.60% 83.58% 116.04% 124.85% 100.00%
Total Cost 30,472 27,503 22,356 21,245 24,004 23,265 21,907 6.49%
  YoY % 10.80% 23.02% 5.23% -11.49% 3.18% 6.20% -
  Horiz. % 139.10% 125.54% 102.05% 96.98% 109.57% 106.20% 100.00%
Net Worth 96,235 95,510 90,595 91,249 80,582 78,162 77,376 4.24%
  YoY % 0.76% 5.42% -0.72% 13.24% 3.09% 1.02% -
  Horiz. % 124.37% 123.44% 117.08% 117.93% 104.14% 101.02% 100.00%
Dividend
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 96,235 95,510 90,595 91,249 80,582 78,162 77,376 4.24%
  YoY % 0.76% 5.42% -0.72% 13.24% 3.09% 1.02% -
  Horiz. % 124.37% 123.44% 117.08% 117.93% 104.14% 101.02% 100.00%
NOSH 105,753 106,122 99,555 100,273 79,784 79,758 79,769 5.52%
  YoY % -0.35% 6.60% -0.72% 25.68% 0.03% -0.01% -
  Horiz. % 132.57% 133.04% 124.80% 125.71% 100.02% 99.99% 100.00%
Ratio Analysis
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 2.47 % 1.86 % 1.96 % 3.33 % 4.42 % 4.08 % 4.52 % -10.87%
  YoY % 32.80% -5.10% -41.14% -24.66% 8.33% -9.73% -
  Horiz. % 54.65% 41.15% 43.36% 73.67% 97.79% 90.27% 100.00%
ROE 0.80 % 0.54 % 0.49 % 0.80 % 1.38 % 1.27 % 1.34 % -9.36%
  YoY % 48.15% 10.20% -38.75% -42.03% 8.66% -5.22% -
  Horiz. % 59.70% 40.30% 36.57% 59.70% 102.99% 94.78% 100.00%
Per Share
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 29.54 26.41 22.91 21.92 31.48 30.41 28.76 0.51%
  YoY % 11.85% 15.28% 4.52% -30.37% 3.52% 5.74% -
  Horiz. % 102.71% 91.83% 79.66% 76.22% 109.46% 105.74% 100.00%
EPS 0.73 0.49 0.45 0.73 1.39 1.24 1.30 -10.41%
  YoY % 48.98% 8.89% -38.36% -47.48% 12.10% -4.62% -
  Horiz. % 56.15% 37.69% 34.62% 56.15% 106.92% 95.38% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.9100 0.9000 0.9100 0.9100 1.0100 0.9800 0.9700 -1.21%
  YoY % 1.11% -1.10% 0.00% -9.90% 3.06% 1.03% -
  Horiz. % 93.81% 92.78% 93.81% 93.81% 104.12% 101.03% 100.00%
Adjusted Per Share Value based on latest NOSH - 820,679
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 3.81 3.41 2.78 2.68 3.06 2.96 2.80 6.04%
  YoY % 11.73% 22.66% 3.73% -12.42% 3.38% 5.71% -
  Horiz. % 136.07% 121.79% 99.29% 95.71% 109.29% 105.71% 100.00%
EPS 0.09 0.06 0.05 0.09 0.14 0.12 0.13 -6.77%
  YoY % 50.00% 20.00% -44.44% -35.71% 16.67% -7.69% -
  Horiz. % 69.23% 46.15% 38.46% 69.23% 107.69% 92.31% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1173 0.1164 0.1104 0.1112 0.0982 0.0952 0.0943 4.25%
  YoY % 0.77% 5.43% -0.72% 13.24% 3.15% 0.95% -
  Horiz. % 124.39% 123.44% 117.07% 117.92% 104.14% 100.95% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/03/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 0.6500 0.7400 0.6550 0.6200 0.5300 0.4800 0.6700 -
P/RPS 2.20 2.80 2.86 2.83 1.68 1.58 2.33 -1.09%
  YoY % -21.43% -2.10% 1.06% 68.45% 6.33% -32.19% -
  Horiz. % 94.42% 120.17% 122.75% 121.46% 72.10% 67.81% 100.00%
P/EPS 89.04 151.02 145.56 84.93 38.13 38.71 51.54 10.98%
  YoY % -41.04% 3.75% 71.39% 122.74% -1.50% -24.89% -
  Horiz. % 172.76% 293.02% 282.42% 164.78% 73.98% 75.11% 100.00%
EY 1.12 0.66 0.69 1.18 2.62 2.58 1.94 -9.94%
  YoY % 69.70% -4.35% -41.53% -54.96% 1.55% 32.99% -
  Horiz. % 57.73% 34.02% 35.57% 60.82% 135.05% 132.99% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.71 0.82 0.72 0.68 0.52 0.49 0.69 0.55%
  YoY % -13.41% 13.89% 5.88% 30.77% 6.12% -28.99% -
  Horiz. % 102.90% 118.84% 104.35% 98.55% 75.36% 71.01% 100.00%
Price Multiplier on Announcement Date
31/03/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 27/05/15 27/02/15 28/02/14 28/02/13 28/02/12 28/02/11 22/02/10 -
Price 0.5650 0.6900 0.7350 0.6000 0.5400 0.5900 0.6400 -
P/RPS 1.91 2.61 3.21 2.74 1.72 1.94 2.23 -2.91%
  YoY % -26.82% -18.69% 17.15% 59.30% -11.34% -13.00% -
  Horiz. % 85.65% 117.04% 143.95% 122.87% 77.13% 87.00% 100.00%
P/EPS 77.40 140.82 163.33 82.19 38.85 47.58 49.23 9.00%
  YoY % -45.04% -13.78% 98.72% 111.56% -18.35% -3.35% -
  Horiz. % 157.22% 286.05% 331.77% 166.95% 78.92% 96.65% 100.00%
EY 1.29 0.71 0.61 1.22 2.57 2.10 2.03 -8.27%
  YoY % 81.69% 16.39% -50.00% -52.53% 22.38% 3.45% -
  Horiz. % 63.55% 34.98% 30.05% 60.10% 126.60% 103.45% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.62 0.77 0.81 0.66 0.53 0.60 0.66 -1.18%
  YoY % -19.48% -4.94% 22.73% 24.53% -11.67% -9.09% -
  Horiz. % 93.94% 116.67% 122.73% 100.00% 80.30% 90.91% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS